AstraZeneca: all 4,196 studies
Page 41 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)CompletedNCT00240318Phase 3
- A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic SyndromeCompletedNCT00240305Phase 3
- Rosuvastatin Impact on Ventricular Remodelling Lipids and CytokinesCompletedNCT00240292Phase 3
- The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA StudyCompletedNCT00240279Phase 3
- Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)CompletedNCT00240266Phase 3
- A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesCompletedNCT00240253Phase 4
- Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast CancerCompletedNCT00239343Phase 2
- Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin TherapyCompletedNCT00239330Phase 3
- Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerCompletedNCT00239304Phase 1/2
- Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate CancerCompletedNCT00239291Phase 1/2
- Budesonide / Formoterol in Treatment of Exacerbations of COPDCompletedNCT00239278Phase 2
- A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma MultiformeCompletedNCT00238797Phase 2
- SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & AdultsCompletedNCT00238784Phase 3
- Gefitinib in Combination With Chemoradiation in Resectable Gastric CancerTerminatedNCT00237900Phase 1/2
- Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart DiseaseCompletedNCT00235950Phase 4
- Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus ZoladexCompletedNCT00235937Phase 2
- Symbicort Single Inhaler Therapy for Asthma in a General Practice SettingCompletedNCT00235911Phase 3
- Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLCTerminatedNCT00234468Phase 3
- Iressa in the Treatment of Brain Metastases From Non Small Cell Lung CancerTerminatedNCT00234442Phase 2
- A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal CarcinomaCompletedNCT00234429Phase 2/3
- IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic CancerCompletedNCT00234416Phase 1/2
- A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast CancerCompletedNCT00234403Phase 2
- PreAsthmaControl (PAC)CompletedNCT00234390Phase 4
- Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With SchizophreniaCompletedNCT00234377Phase 3
- DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European GuidelinesCompletedNCT00233649
- Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT00233636Phase 2
- Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWithdrawnNCT00233623Phase 2
- Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate CancerCompletedNCT00233610Phase 3
- Pulmicort Asthma Prevention (Post-PAC)CompletedNCT00233584Not applicable
- Efficacy Study of the Effect of Budesonide on EmphysemaCompletedNCT00232674Phase 4
- PROACT - Pre-Operative Arimidex Compared To TamoxifenCompletedNCT00232661Phase 3
- Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial AsthmaCompletedNCT00232648Phase 3
- Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer SubjectsCompletedNCT00230516Phase 4
- GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 DiabetesTerminatedNCT00229710Phase 3
- Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa StudyCompletedNCT00229697Phase 2
- ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)TerminatedNCT00229684Phase 2
- Esomeprazole for Treatment of GERD in Pediatric PatientsCompletedNCT00228527Phase 4
- Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub StudyCompletedNCT00228514Phase 3
- Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck CarcinomaCompletedNCT00228488Phase 2
- A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic WomenCompletedNCT00228475Phase 4
- Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or PlaceboCompletedNCT00228462Phase 3
- TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention TrialCompletedNCT00227318Phase 3
- GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusTerminatedNCT00226330Phase 3
- A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)CompletedNCT00225589Phase 3
- Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male AdultsCompletedNCT00224783Phase 1
- Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And OlderCompletedNCT00217230Phase 3
- LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary SyndromesCompletedNCT00214630Phase 3
- Type III DysbetalipoproteinemiaCompletedNCT00214604Phase 3
- GALLANT 5 Tesaglitazar Versus MetforminTerminatedNCT00214591Phase 3
- Seroquel on Glucose MetabolismCompletedNCT00214578Phase 4
- GALLANT 6 Tesaglitazar vs. PioglitazoneTerminatedNCT00214565Phase 3
- Crestor Versus Placebo in Subjects With Heart FailureCompletedNCT00206310Phase 3
- A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.CompletedNCT00206284Phase 2
- A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.CompletedNCT00206245Phase 2
- Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)CompletedNCT00206219Phase 3
- NEXIUM® in the Treatment of Moderate and Severe Erosive EsophagitisCompletedNCT00206180Phase 4
- A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDCompletedNCT00206167Phase 3
- A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsCompletedNCT00206154Phase 3
- Seroquel in Bipolar Depression Versus LithiumCompletedNCT00206141Phase 3
- Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With SchizophreniaCompletedNCT00206128Phase 3
- SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With SchizophreniaCompletedNCT00206115Phase 3
- Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic EventsTerminatedNCT00206089Phase 3
- Long Term Open Follow-up With H376/95 vs. WarfarinTerminatedNCT00206063Phase 2
- Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg poCompletedNCT00206050Phase 4
- Acid-Associated Heartburn Symptoms and Dose of EsomeprazoleCompletedNCT00206024Phase 4
- Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque PsoriasisCompletedNCT00192517Phase 2
- Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNCT00192491Phase 3
- Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524CompletedNCT00192478Phase 1/2
- Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy AdultsCompletedNCT00192465Phase 1
- Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque PsoriasisCompletedNCT00192452Phase 2
- Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High RiskCompletedNCT00192439
- Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.CompletedNCT00192426Phase 3
- Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed InfluenzaCompletedNCT00192413Phase 3
- Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.CompletedNCT00192400Phase 3
- Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)CompletedNCT00192387Phase 2
- Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy ChildrenCompletedNCT00192374Phase 3
- Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)CompletedNCT00192361Phase 3
- A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy InfantsCompletedNCT00192348Phase 1
- Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy ParticipantsCompletedNCT00192335Phase 3
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy ChildrenCompletedNCT00192322Phase 2
- Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.CompletedNCT00192309Phase 2
- Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care CentersCompletedNCT00192283Phase 3
- Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy ChildrenCompletedNCT00192270Phase 2
- Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With AsthmaCompletedNCT00192257Phase 3
- Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy ChildrenCompletedNCT00192244Phase 3
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)CompletedNCT00192231Phase 3
- Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention ProgramCompletedNCT00192218Phase 4
- Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in ChildrenCompletedNCT00192205Phase 3
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy AdultsCompletedNCT00192192Phase 3
- A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.CompletedNCT00192179Phase 2
- Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 MonthsCompletedNCT00192166Phase 2
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and OlderCompletedNCT00192153Phase 2
- Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of AgeCompletedNCT00192140Phase 4
- Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy AdultsCompletedNCT00192127Phase 3
- A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese SubjectsCompletedNCT00189514Phase 2
- Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)CompletedNCT00163527Phase 3
- Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)CompletedNCT00163514Phase 3
- Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)CompletedNCT00163501Phase 3
- Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)CompletedNCT00163488Phase 3
- Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)CompletedNCT00163475Phase 3